BIOLOGICAL RHYTHMS IN THE PHYSIOLOGY AND PHARMACOLOGY OF BLOOD-COAGULATION

被引:26
作者
LABRECQUE, G
SOULBAN, G
机构
[1] Ecole de Pharmacie and Département de Pharmacie, Centre Hospitalier de I'Université Laval, Québec
[2] Schering Canada Inc., Montréal, Qukbec
关键词
ACTIVATED PARTIAL THROMBOPLASTIN TIME; BIOLOGICAL RHYTHMS; BLOOD COAGULATION FACTORS; CLOTTING TIME; HEPARIN; THROMBIN TIME; PLATELET AGGREGATION; VITAMIN-K CYCLE; WARFARIN;
D O I
10.3109/07420529109059172
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
This article reviews the current knowledge on time-dependent variations in the physiology of blood coagulation and in the anticoagulant effect of heparin and warfarin. Animal data indicated that the shortest blood clotting time and the highest levels of coagulation factors II, VII, and IX were recorded during the resting period of the animal. These circadian rhythms were not altered by modifications of the lighting regimens. In healthy volunteers, the prothrombin time was longer at the end of the afternoon than early in the morning; the acrophases of activated partial thromboplastin time and thrombin time occurred in the evening or during the night. The acrophases of fibrinogen, factors II, VII, VIII, and a-1-antitrypsin were obtained in the morning. There is no agreement on the chronobiology of platelet aggregation, and differences can be found in the time of maximal aggregability. The chronopharmacological studies of heparin infused at a constant rate to patients with thromboembolic diseases suggested that maximal effectiveness occurred at 04:00, while it was minimal at 08:00. Animal data indicated that oral administration of warfarin at the end of the activity period of rats produced maximal inhibition of vitamin K-dependent factors. This was the time of day when warfarin interference with the vitamin K cycle of the liver was highest. Further studies are needed to determine the clinical significance of biological rhythms in the physiology and pharmacology of blood coagulation.
引用
收藏
页码:361 / 372
页数:12
相关论文
共 45 条
  • [1] Zucker M., Platelet function, Hematology, pp. 1176-1184, (1983)
  • [2] O'Reilley R., Anticoagulant, antithrombotic and thrombolytic drugs, Thepharmacological basis eflherapeutics., pp. 1338-1359, (1985)
  • [3] Williams W., Mechanism of coagulation, Hematology., pp. 1238-1246, (1983)
  • [4] Lemmer B., Temporal aspects of the effects of cardiovascular active drugs in humans, Chronopharinacology: cellular and biochemical interactions., pp. 525-541, (1989)
  • [5] Kaneko M., Zechman F.W., Smith R.E., Circadian variation in human peripheral blood flow levels and exercise response, J Appl Physiol, 25, pp. 109-114, (1968)
  • [6] Labrecque G., Bilanger P.M., Dork F., Lalande M., Twenty-four-hour variations in the distribution of labeled microspheres to the intestine, liver and kidneys, Ann Rev Chronopharmacol, 5, pp. 445-448, (1988)
  • [7] Haus E., Cusulos M., Sackett-Lundeen L., Swoyer J., Circadian variations in blood coagulation parameters: alpha-antitrypsin antigen and platelet aggregation and retention in clinically healthy subjects, Chronobiol Int, 7, pp. 203-216, (1990)
  • [8] Master A.M., Jaffee J.L., Factors in the onset of coronary occlusion and coronary insufficiency, J Am Med Assoc, 148, pp. 794-798, (1952)
  • [9] Reinberg A., Gervais P., Halberg F., Gaultier M., Poynette N., Albuker N., Dupont J., Mortalite des adultes. Rythmes circadiens et circannuels, Nouv Presse Med, 2, pp. 289-294, (1973)
  • [10] Muller J.E., Stone P.H., Turis S.G., Et al., Circadian variation in the frequency of onset of sudden cardiac death, New Engl J Med, 313, pp. 1315-1322, (1985)